Gossamer Bio, Inc. logo

Gossamer Bio, Inc. (GOSS) Q1 2025 Earnings

GOSS·Reported May 15, 2025·After market close

Gossamer Bio, Inc. reported Q1 2025 revenue of $9.9M, beat analyst consensus of $3.9M by $5.9M. Diluted EPS came in at $-0.16 (+15.8% YoY), beat the $-0.18 consensus by $0.02.

Revenue
$9.9Mbeat by $5.9M
Consensus: $3.9M
Diluted EPS
$-0.16beat by $0.02
Consensus: $-0.18
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0001728117-25-000036

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Gossamer Bio, Inc.'s Q1 2025 earnings report.

Gossamer Bio, Inc. (GOSS) reported Q1 2025 earnings on May 15, 2025 after market close.

Gossamer Bio, Inc. reported revenue of $9.9M and diluted EPS of $-0.16 for Q1 2025.

Revenue beat the consensus estimate of $3.9M by $5.9M. EPS beat the consensus estimate of $-0.18 by $0.02.

Compared to the same quarter a year prior, diluted EPS grew 15.8% from $-0.19.

You can read the 10-Q periodic report (0001728117-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.